Recent evidence suggests that the postprandial hyperglycaemia in impai
red glucose tolerance is primarily due to impaired suppression of basa
l hepatic glucose output. This in turn appears to be secondary to decr
eased first phase insulin secretion, although decreased hepatic insuli
n sensitivity, which is a feature of non-insulin-dependent diabetes me
llitus, might also play a role. Eight mildly overweight subjects with
impaired glucose tolerance and eight closely matched control subjects
with normal glucose tolerance underwent an intravenous glucose toleran
ce test to assess first phase insulin secretion. Insulin sensitivity w
as examined by a 150-min hyperinsulinaemic-euglycaemic clamp. Somatost
atin was infused from 150 min to suppress endogenous insulin secretion
, and glucagon and insulin were replaced by constant infusion, Glucose
with added dideuterated glucose (labelled infusion technique) was inf
used to maintain euglycaemia. First phase insulin secretion (Delta 0-1
0 min insulin area divided by Delta 0-10 min glucose area) was signifi
cantly decreased in the subjects with impaired glucose tolerance (medi
an [range]: 1.2 [0.2-19.4] vs 9.1 [2.6-14.5] mU . mmol(-1); p < 0.01).
During the clamp, circulating insulin (93 +/- 8 [mean +/- SEM] and 81
+/- 10 mU . l(-1)) and glucagon (54 +/- 4 and 44 +/- 6 ng . l(-1)) le
vels were comparable, Total glucose disposal was decreased in subjects
with impaired glucose tolerance (2.78 +/- 0.27 vs 4.47 +/- 0.53 mg .
kg(-1). min(-1); p < 0.02), and was primarily due to decreased non-oxi
dative glucose disposal. However, hepatic glucose output rates were co
mparable during the clamp (0.38 +/- 0.10 and 0.30 +/- 0.18 mg . kg(-1)
. min(-1)). Therefore, the main defects in subjects with impaired gluc
ose tolerance are decreased first phase insulin secretion and peripher
al non-oxidative glucose disposal, but hepatic glucose output shows no
rmal responsiveness to insulin.